A Comment on "The Valuation of R&D Firms with R&D Limited Partnerships."
评论了Shevlin关于研发有限合伙作为看涨期权的解释，批评了其资产和负债成分的测量方法，对估值研究者有参考价值。
Abstract Comments on the article titled, `The Valuation of R&D Firms with R&D Limited Partnerships,' by Terry Shevlin to clarify his interpretation of the components of the research and development (R&D) limited partnership (LP) as a call option reflected in the firm's stock price. Criticism on the measurement of the asset and liability components of the LP in the option pricing network.